The efficacy of targeted and immune-based therapies in adults with TP53-mutated acute lymphoblastic leukaemia. Pourhassan H, Tinajero J, Ma H, Jackson R, et al. Br J Haematol 2025;207:1377-1387.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pourhassan H, Tinajero J, Ma H, Jackson R, et al. The efficacy of targeted and immune-based therapies in adults with TP53-mutated acute lymphoblastic leukaemia. Br J Haematol 2025;207:1377-1387.
PMID: 40890465